Dr. Reddy’s Laboratories Ltd. has introduced Doxycycline Capsules, 40 mg in the US market. 

According to the company’s press statement, it is a therapeutic generic equivalent of ORACEA (doxycycline, USP) Capsules, 40 mg approved by the US Food and Drug Administration (USFDA).

Dr. Reddy’s Doxycycline Capsules, 40 mg, are supplied in bottle counts of 30. ORACEA is a trademark of Galderma Holdings, S.A.

It is a broad-spectrum antibiotic and it is used in the treatment of infections caused by bacteria and certain parasites. It is used to treat bacterial pneumonia, acne, chlamydia infections, Lyme disease, cholera, typhus, and syphilis. It is also used to prevent malaria.

Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products, Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Their major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.